Shandong Buchang Pharmaceuticals has taken part in a $17.7m round for Symbow Medical, which is working on a surgical navigation device.

China-based medical device developer Symbow Medical has raised RMB120m ($17.7m) in a series A round that included pharmaceutical firm Shandong Buchang Pharmaceuticals, China Money Network reported today.

The round was led by investment fund Huayi Capital and also featured state-owned National Emerging Industry Guidance Fund and venture capital firm Sangel Capital. Symbow Medical has not revealed any previous funding rounds.

Founded in 2011, Symbow Medical has developed a surgical navigation device that reduces the risk of instrument displacement during breast…